Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters











Database
Language
Publication year range
1.
Transplantation ; 90(11): 1157-64, 2010 Dec 15.
Article in English | MEDLINE | ID: mdl-21048535

ABSTRACT

BACKGROUND: The causes of endothelial dysfunction after cardiac transplantation are unknown. Here, we have investigated whether the indirect alloimmune response mediates endothelial dysfunction in a major histocompatibility complex class I mismatch model. METHODS: PVG.RT1 rat hearts were transplanted into thymectomized CD8 T-cell-depleted allogeneic (PVG.R8) or syngeneic (PVG.RT1) recipients. Alloantibody was assessed at 2, 4, and 8 weeks. Cardiac allograft vasculopathy, the nature of the inflammatory infiltrate, and origin of endothelial cells were examined at 1, 2, 4, and 8 weeks. Endothelial function was assessed by Langendorff preparations at 1, 2, and 4 weeks. RESULTS: Recipients produced alloantibody and showed luminal occlusion at 1 (17.7%±8.0%), 2 (23.2%±4.9%), 4 (34.3%±5.0%), and 8 weeks (58.1%±1.8%) posttransplantation. The major inflammatory features of the allografts consisted of CD11b monocytes, CD4 T cells, and C4d deposition. At 1 week, the basal coronary flow and the vasodilator response to 5-hydroxytrytamine of syngeneic and allografted hearts were inhibited compared with normal hearts. At 4 weeks, the basal coronary flow of allografts was 54% lower than syngrafts (P<0.01), and 5- hydroxytrytamine and sodium nitroprusside did not evoke an increase in coronary flow in the allograft heart compared with syngeneic controls (P<0.01). Culture of aortic rings with antibody to major histocompatibility complex class I inhibited endothelium-dependent vasodilation to acetylcholine. CONCLUSION: Transient microvascular endothelial dysfunction occurred in syngeneic and allogeneic cardiac grafts after transplantation. Syngeneic but not allogeneic grafts recovered, suggesting the indirect immune response, consisting of CD4 T cells, monocytes, and antibody, mediates endothelial dysfunction. A possible role for alloantibody in endothelial dysfunction is discussed.


Subject(s)
Coronary Circulation , Coronary Vessels/transplantation , Endothelium, Vascular/transplantation , Heart Transplantation/immunology , Isoantibodies/blood , Microcirculation , Vasodilation , Animals , CD11b Antigen/immunology , CD4-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/immunology , Complement C4b/immunology , Coronary Circulation/drug effects , Coronary Circulation/immunology , Coronary Occlusion/immunology , Coronary Vessels/drug effects , Coronary Vessels/immunology , Coronary Vessels/physiopathology , Dose-Response Relationship, Drug , Endothelium, Vascular/drug effects , Endothelium, Vascular/immunology , Endothelium, Vascular/physiopathology , Histocompatibility Antigens Class I/immunology , Inflammation Mediators/immunology , Microcirculation/drug effects , Microcirculation/immunology , Monocytes/immunology , Peptide Fragments/immunology , Perfusion , Rats , Thymectomy , Time Factors , Transplantation, Homologous , Transplantation, Isogeneic , Vasodilation/drug effects , Vasodilation/immunology , Vasodilator Agents/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL